Outcome | Studies | Participants | Risk Ratio (M-H, Fixed, 95% CI), I2 |
---|---|---|---|
Tamoxifen (20 mg daily) versus anastrozole (1 mg daily) | Â | Â | Â |
Treatment of breast events | Â | Â | Â |
   • at 3 months | Saltzstein 2005 | 90 | 0.38 (0.25, 0.58), - |
Tamoxifen (10 mg daily) versus radiotherapy | Â | Â | Â |
Treatment of gynecomastia/breast pain/or both | Â | Â | Â |
   • after 9 months | Perdona 2005 | 35 | 0.21 (0.05, 0.83), - |